The 11 analysts offering 12-month price forecasts for Krystal Biotech Inc have a median target of 154.00, with a high estimate of 168.00 and a low estimate of 130.00. The median estimate represents a +44.89% increase from the last price of 106.29.
The current consensus among 12 polled investment analysts is to Buy stock in Krystal Biotech Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.09
Reporting Date Mar 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.